17 members of Congress have disclosed 118 trades in Vertex Pharmaceuticals Inc / Ma (VRTX) since 2016: 65 purchases worth about $642.53K and 53 sales worth about $620.03K. The most active was Ro Khanna, with 80 trades. The latest trade was made on Sep 4, 2026.
VRTX’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought VRTX, a red one a day they sold; hover for who and how much.
| # | Member | Trades | Buys | Sells | Bought (est.) | Sold (est.) | Net | Buys vs SPY | First Traded | Last Traded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ro KhannaD-CA | 80 | 49 | 31 | $465.52K | $370.52K | +$95.01K | +25.8% | May 2, 2017 | Sep 4, 2026 |
| 2 | David J. TaylorR-OH | 3 | 1 | 2 | $8.00K | $16.00K | -$8.00K | +28.3% | Aug 7, 2025 | Aug 26, 2026 |
| 3 | Julia LetlowR-LA | 1 | 1 | 0 | $8.00K | $0.00 | +$8.00K | -12.5% | Oct 23, 2024 | Oct 23, 2024 |
| 4 | Lisa C. McClainR-MI | 3 | 1 | 2 | $8.00K | $16.00K | -$8.00K | -5.7% | Dec 11, 2024 | Jun 11, 2025 |
| 5 | Jefferson ShreveR-IN | 3 | 2 | 1 | $65.00K | $32.50K | +$32.50K | -18.8% | Feb 24, 2025 | May 12, 2025 |
| 6 | Byron DonaldsR-FL | 4 | 2 | 2 | $16.00K | $16.00K | $0.00 | -17.1% | Dec 7, 2022 | Mar 20, 2025 |
| 7 | Greg StantonD-AZ | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | -19.3% | Sep 26, 2023 | Oct 24, 2023 |
| 8 | William R. KeatingD-MA | 1 | 1 | 0 | $8.00K | $0.00 | +$8.00K | +51.5% | Mar 29, 2022 | Mar 29, 2022 |
| 9 | Diana HarshbargerR-TN | 1 | 0 | 1 | $0.00 | $8.00K | -$8.00K | – | Sep 1, 2021 | Sep 1, 2021 |
| 10 | Peter MeijerR-MI | 1 | 0 | 1 | $0.00 | $8.00K | -$8.00K | – | Jan 28, 2021 | Jan 28, 2021 |
| 11 | Dean PhillipsD-MN | 1 | 1 | 0 | $8.00K | $0.00 | +$8.00K | +29.9% | Dec 18, 2020 | Dec 18, 2020 |
| 12 | Donna E. ShalalaD-FL | 2 | 1 | 1 | $8.00K | $8.00K | $0.00 | +69.6% | Apr 18, 2019 | Jun 24, 2019 |
| 13 | Josh GottheimerD-NJ | 6 | 2 | 4 | $16.00K | $32.00K | -$16.00K | +102.2% | Apr 13, 2017 | Sep 19, 2019 |
| 14 | Gilbert Ray Cisneros, Jr.D-CA | 3 | 0 | 3 | $0.00 | $73.00K | -$73.00K | – | Jan 31, 2019 | Feb 27, 2019 |
| 15 | Francis RooneyR-FL | 3 | 1 | 2 | $8.00K | $16.00K | -$8.00K | +302.5% | Jan 4, 2017 | Feb 1, 2018 |
| Owner | Type | Filing | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Spouse | Buy | $1K–$15K | Sep 4, 2026 | Oct 7, 2026 | 33d | +1.3% | +3.6% | |
| David J. TaylorR-OH | VRTXVertex Pharmaceuticals Incorporated - Common Stock | Self | Sell | $1K–$15K | Aug 26, 2026 | Sep 5, 2026 | 10d | +1.1% | +2.9% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Dependent Child | Buy | $1K–$15K | Jun 2, 2026 | Jul 6, 2026 | 34d | +30.1% | +31.1% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Spouse | Sell (Partial) | $1K–$15K | May 27, 2026 | Jun 9, 2026 | 13d | +26.5% | +26.3% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Spouse | Buy | $1K–$15K | Apr 13, 2026 | May 11, 2026 | 28d | +25.7% | +16.1% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Spouse | Buy | $1K–$15K | Apr 24, 2026 | May 11, 2026 | 17d | +28.6% | +23.2% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Dependent Child | Sell (Partial) | $1K–$15K | Mar 30, 2026 | Apr 7, 2026 | 8d | +24.8% | +5.8% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | – | Buy | $1K–$15K | Mar 23, 2026 | Apr 7, 2026 | 15d | +22.6% | +7.8% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Spouse | Sell (Partial) | $15K–$50K | Feb 5, 2026 | Mar 9, 2026 | 32d | +20.6% | +9.6% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Dependent Child | Buy | $1K–$15K | Jan 23, 2026 | Feb 6, 2026 | 14d | +18.1% | +9.0% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO Q | Spouse | Buy | $15K–$50K | Jan 29, 2026 | Feb 6, 2026 | 8d | +16.3% | +7.9% | |
| David J. TaylorR-OH | VRTXVertex Pharmaceuticals Incorporated - Common Stock | Self | Sell | $1K–$15K | Jan 29, 2026 | Feb 2, 2026 | 4d | +16.3% | +7.9% | |
| Julia LetlowR-LA | VRTXVertex Pharmaceuticals Incorporated - Common Stock | Self | Buy | $1K–$15K | Oct 23, 2024 | Jan 13, 2026 | 447d late | +17.7% | -12.5% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Spouse | Buy | $1K–$15K | Oct 7, 2025 | Nov 6, 2025 | 30d | +34.8% | +22.4% | |
| Ro KhannaD-CA | VRTXVERTEX PHARMACEUTICALS INCORPO CMN | Spouse | Sell (Partial) | $1K–$15K | Sep 5, 2025 | Oct 3, 2025 | 28d | +39.6% | +23.4% |
Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.
17 members of Congress have disclosed 118 trades in Vertex Pharmaceuticals Inc / Ma (VRTX) since 2016: 65 purchases worth about $642.53K and 53 sales worth about $620.03K. The most active was Ro Khanna, with 80 trades. The latest trade was made on Sep 4, 2026. Most active: Ro Khanna (80), David J. Taylor (3), Julia Letlow (1), Lisa C. McClain (3), Jefferson Shreve (3).
Since 2016 they have disclosed 65 purchases and 53 sales; by the midpoints of the disclosed ranges, about $642.53K bought and $620.03K sold, a net purchase of $22.51K.
Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded VRTX on its price, against the S&P 500 over the same days.
Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.